Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Faculty of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy; Faculty of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Resuscitation. 2020 Dec;157:241-247. doi: 10.1016/j.resuscitation.2020.10.020. Epub 2020 Oct 29.
INTRODUCTION: In addition to the directly attributed mortality, COVID-19 is also likely to increase mortality indirectly. In this systematic review, we investigate the direct and indirect effects of COVID-19 on out-of-hospital cardiac arrests. METHODS: We searched PubMed, BioMedCentral, Embase and the Cochrane Central Register of Controlled Trials for studies comparing out-of-hospital cardiac arrests occurring during the pandemic and a non-pandemic period. Risk of bias was assessed with the ROBINS-I tool. The primary endpoint was return of spontaneous circulation. Secondary endpoints were bystander-initiated cardiopulmonary resuscitation, survival to hospital discharge, and survival with favourable neurological outcome. RESULTS: We identified six studies. In two studies, rates of return of spontaneous circulation and survival to hospital discharge decreased significantly during the pandemic. Especially in Europe, bystander-witnessed cases, bystander-initiated cardiopulmonary resuscitation and resuscitation attempted by emergency medical services were reduced during the pandemic. Also, ambulance response times were significantly delayed across all studies and patients presenting with non-shockable rhythms increased in two studies. In 2020, 3.9-5.9% of tested patients were SARS-CoV-2 positive and 4.8-26% had suggestive symptoms (fever and cough or dyspnoea). CONCLUSIONS: Out-of-hospital cardiac arrests had worse short-term outcomes during the pandemic than a non-pandemic period suggesting direct effects of COVID-19 infection and indirect effects from lockdown and disruption of healthcare systems. Patients at high risk of deterioration should be identified outside the hospital to promptly initiate treatment and reduce fatalities. Study registration PROSPERO CRD42020195794.
简介:除了直接归因的死亡率外,COVID-19 还可能间接地导致死亡率增加。在本系统评价中,我们研究了 COVID-19 对院外心脏骤停的直接和间接影响。
方法:我们在 PubMed、BioMedCentral、Embase 和 Cochrane 对照试验中心注册库中搜索了比较大流行期间和非大流行期间发生的院外心脏骤停的研究。使用 ROBINS-I 工具评估偏倚风险。主要终点是自主循环恢复。次要终点包括旁观者启动的心肺复苏、存活至出院和有良好神经结局的存活。
结果:我们确定了六项研究。在两项研究中,自主循环恢复率和存活至出院的比率在大流行期间显著下降。特别是在欧洲,大流行期间旁观者目击病例、旁观者启动的心肺复苏和紧急医疗服务的复苏尝试减少。此外,所有研究的救护车反应时间均显著延迟,两项研究中出现非可除颤节律的患者增加。2020 年,3.9%-5.9%的检测患者 SARS-CoV-2 阳性,4.8%-26%有提示症状(发热和咳嗽或呼吸困难)。
结论:与非大流行期间相比,院外心脏骤停在大流行期间的短期预后更差,提示 COVID-19 感染的直接影响以及封锁和医疗保健系统中断的间接影响。应在医院外识别出高危恶化的患者,以便及时启动治疗并降低死亡率。研究注册 PROSPERO CRD42020195794。
Resuscitation. 2020-12
Resuscitation. 2020-8-3
Am J Emerg Med. 2021-8
BMC Cardiovasc Disord. 2025-3-7
Resusc Plus. 2025-1-11
Rev Cardiovasc Med. 2025-1-22
Pathog Glob Health. 2020-9
Resuscitation. 2020-6-7
Lancet Public Health. 2020-5-27